Standard BioTools Inc. (LAB)

Standard BioTools Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	150.88	166.73	51.7	81.31	28.45	68.52
Short-Term Investments	107.18	126.15	63.19	84.48	-	-
Cash & Short-Term Investments	258.06	292.87	114.9	165.78	28.45	68.52
Cash Growth	-44.18%	154.91%	-30.70%	482.70%	-58.48%	16.85%
Accounts Receivable	34	33.41	19.66	17.28	18.32	25.42
Other Receivables	1.48	0.2	-	-	-	-
Receivables	35.48	33.61	19.66	17.28	18.32	25.42
Inventory	42.13	40.74	20.53	21.47	20.83	19.69
Prepaid Expenses	8.35	8.66	3.13	4.28	4.45	4.01
Restricted Cash	-	-	-	-	0.02	0.02
Total Current Assets	344.02	375.88	158.22	208.82	72.07	117.66
Property, Plant & Equipment	71.02	71.38	54.85	59.54	65.15	55.65
Goodwill	111.72	111.3	106.32	106.25	106.38	106.56
Other Intangible Assets	28.06	28.95	1.4	13.18	29.18	42.22
Long-Term Deferred Tax Assets	-	-	-	0.23	0.18	-
Other Long-Term Assets	24.79	24.83	2.29	2.3	2.25	2.66
Total Assets	579.6	612.34	323.07	390.31	275.21	324.76
Accounts Payable	11.78	12.28	9.24	7.91	10.6	9.22
Accrued Expenses	13.99	21.61	16.09	7.52	13.59	24.01
Short-Term Debt	-	-	-	-	6.84	-
Current Portion of Long-Term Debt	-	-	59.53	2.08	-	-
Current Portion of Leases	6.33	6.23	4.32	3.68	3.05	2.97
Current Income Taxes Payable	-	-	-	1.44	-	-
Current Unearned Revenue	16.15	16.65	15.22	14.44	15.48	16.39
Other Current Liabilities	7.98	9.13	4.93	6.37	-	1.66
Total Current Liabilities	56.24	65.89	109.33	43.44	49.57	54.25
Long-Term Debt	0.3	0.3	3.98	62.81	64.21	54.22
Long-Term Leases	24.9	26.47	30.37	34.08	37.55	38.18
Long-Term Unearned Revenue	39.05	39.92	14.28	18.18	24.08	29.03
Long-Term Deferred Tax Liabilities	1.03	1.08	0.84	1.06	4.33	8.7
Other Long-Term Liabilities	3.49	6.96	1.07	0.96	0.88	1.33
Total Liabilities	125	140.62	159.87	160.52	180.62	185.71
Common Stock	0.4	0.4	0.08	0.08	0.08	0.08
Additional Paid-In Capital	1,711	1,702	860.82	847.01	831.42	815.62
Retained Earnings	-1,212	-1,186	-1,001	-926.1	-736	-676.76
Treasury Stock	-46.47	-46.47	-5.98	-0.56	-	-
Comprehensive Income & Other	1.17	1.23	-2.22	-1.9	-0.91	0.11
Total Common Equity	454.6	471.72	-148.05	-81.47	94.6	139.05
Shareholders' Equity	454.6	471.72	163.2	229.79	94.6	139.05
Total Liabilities & Equity	579.6	612.34	323.07	390.31	275.21	324.76
Total Debt	31.53	33	98.21	102.66	111.65	95.38
Net Cash (Debt)	226.53	259.88	16.69	63.13	-83.2	-26.86
Net Cash Growth	-38.84%	1457.56%	-73.57%	-	-	-
Net Cash Per Share	0.61	0.74	0.21	0.81	-1.10	-0.37
Filing Date Shares Outstanding	379.82	378.99	290.12	79.06	77.2	74.55
Total Common Shares Outstanding	379.09	377.53	80.23	79.48	76.92	74.54
Working Capital	287.78	309.99	48.89	165.37	22.5	63.41
Book Value Per Share	1.20	1.25	-1.85	-1.02	1.23	1.87
Tangible Book Value	314.82	331.47	-255.77	-200.9	-40.97	-9.74
Tangible Book Value Per Share	0.83	0.88	-3.19	-2.53	-0.53	-0.13
Buildings	3.48	3.48	1.76	1.71	-	-
Machinery	68.56	68.55	41.8	39.12	38.09	24.34
Construction In Progress	6.99	9.46	2.33	1.61	4.55	9.98
Leasehold Improvements	17.47	17.45	13.79	12.23	12.1	7.2

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q